Your Article Summary
See Latest ArticlesThe Use of Antifibrinolytic Agents in Spine Surgery
Journal of Bone and Joint Surgery, 11/10/08
Gill JB et al. - Aprotinin, tranexamic acid, and epsilon-aminocaproic acid are effective for reducing blood loss and transfusions in patients managed with spine surgery. With the exception of aprotinin, the side-effect profiles of these agents have not been shown to cause any substantial morbidity or to increase the rate of thromboembolic events. Epsilon-aminocaproic acid had a greater effect on reducing blood transfusions as the complexity of surgery increased. The surgeon and/or the anesthesiologist should consider the use of antifibrinolytic agents for patients undergoing spinal procedures in which a large amount of blood loss can be expected; however, at the present time, this is not a United States Food and Drug Administration-approved indication for these agents.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
Today in Ortho/Rheum...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Hospital-Based Chiropractic Integration Within a Large Private Hospital System in Minnesota: A 10-Year Example
Journal of Manipulative and Physiological Therapeutics, 12/17/09
Intraoperative Computed Tomography With Integrated Navigation System in Spinal Stabilizations
Spine, 12/17/09